Therapeutics

Developing drugs that target novel biological pathways

Learn More

Highlights

  • May 07, 2012:   Repligen Announces Support of Amended Stockholder Proposal   More
  • May 03, 2012:   Repligen Reports First Quarter 2012 Financial Results   More
  • Apr 30, 2012:   Repligen Announces Conference Call to Report First Quarter of 2012 Financial Results   More